Overview
Melanie Morin practices in Sherbrooke, Canada. Ms. Morin and is rated as an Elite expert by MediFind in the treatment of Vulvodynia. Her top areas of expertise are Vulvodynia, Pelvic Floor Dysfunction, Urinary Incontinence, and Stress Urinary Incontinence.
Her clinical research consists of co-authoring 93 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 21 articles and participated in 2 clinical trials in the study of Vulvodynia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- VulvodyniaMs. Morin isElite. Learn about Vulvodynia.
- Distinguished
- Pelvic Floor DysfunctionMs. Morin isDistinguished. Learn about Pelvic Floor Dysfunction.
- Urinary IncontinenceMs. Morin isDistinguished. Learn about Urinary Incontinence.
- Advanced
- Stress Urinary IncontinenceMs. Morin isAdvanced. Learn about Stress Urinary Incontinence.
- Experienced
- Acute PainMs. Morin isExperienced. Learn about Acute Pain.
- Chronic PainMs. Morin isExperienced. Learn about Chronic Pain.
- FibromyalgiaMs. Morin isExperienced. Learn about Fibromyalgia.
- MenopauseMs. Morin isExperienced. Learn about Menopause.
- Myotonic DystrophyMs. Morin isExperienced. Learn about Myotonic Dystrophy.
- Myotonic Dystrophy Type 2Ms. Morin isExperienced. Learn about Myotonic Dystrophy Type 2.